Cancer Research AACR Membership  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3308-3312, July 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Q.-R.
Right arrow Articles by Mixson, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Q.-R.
Right arrow Articles by Mixson, A. J.
[Cancer Research 59, 3308-3312, July 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Liposomes Complexed to Plasmids Encoding Angiostatin and Endostatin Inhibit Breast Cancer in Nude Mice1

Qing-Rong Chen, Dhruv Kumar, Sanford A. Stass and A. James Mixson2

Department of Pathology and Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201 [Q-R. C., S. A. S., A. J. M.], and Department of Pathology, Sinai Hospital of Baltimore, Baltimore Maryland 21215 [D. K.]

Gene therapy transfer of angiostatin and endostatin represents an alternative method of delivering angiogenic polypeptide inhibitors. We examined whether liposomes complexed to plasmids encoding angiostatin or endostatin inhibited angiogenesis and the growth of MDA-MB-435 tumors implanted in the mammary fat pads of nude mice. We determined that plasmids expressing angiostatin (PCI-Angio) or endostatin (PCI-Endo) effectively reduced angiogenesis using an in vivo Matrigel assay. We then investigated the efficacy of these plasmids in reducing the size of tumors implanted in the mammary fat pad of nude mice. Both PCI-Angio and PCI-Endo significantly reduced tumor size when injected intratumorally (P < 0.05). Compared to the untreated control group, the mice treated with PCI-Angio and PCI-Endo exhibited a reduction in tumor size of 36% and 49%, respectively. In addition, we found that i.v. injections of liposomes complexed to PCI-Endo reduced tumor growth in the nude mice by nearly 40% when compared to either empty vector (PCI) or untreated controls (P < 0.05). These findings provide a basis for the further development of nonviral delivery of antiangiogenic genes.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
B. Schaffhauser, T. Veikkola, K. Strittmatter, H. Antoniadis, K. Alitalo, and G. Christofori
Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice
J. Leukoc. Biol., October 1, 2006; 80(4): 669 - 676.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
X.-P. Li, C. Y.S. Li, X. Li, Y. Ding, L. L.Y. Chan, P.-H. Yang, G. Li, X. Liu, J. S. Lin, J. Wang, et al.
Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin
Mol. Cancer Ther., May 1, 2006; 5(5): 1290 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Zhang, M. Nie, J. Sham, C. Su, H. Xue, D. Chua, W. Wang, Z. Cui, Y. Liu, C. Liu, et al.
Effective Gene-Viral Therapy for Telomerase-Positive Cancers by Selective Replicative-Competent Adenovirus Combining with Endostatin Gene
Cancer Res., August 1, 2004; 64(15): 5390 - 5397.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. I. Kim, K. S. Kim, H. S. Kim, D. S. Kim, Y. Jang, K. H. Chung, and Y. S. Park
Inhibitory Effect of the Salmosin Gene Transferred by Cationic Liposomes on the Progression of B16BL6 Tumors
Cancer Res., October 1, 2003; 63(19): 6458 - 6462.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. Reijerkerk, L. O. Mosnier, O. Kranenburg, B. N. Bouma, P. Carmeliet, T. Drixler, J. C.M. Meijers, E. E. Voest, and M. F.B.G. Gebbink
Amyloid Endostatin Induces Endothelial Cell Detachment by Stimulation of the Plasminogen Activation System
Mol. Cancer Res., June 1, 2003; 1(8): 561 - 568.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Saimura, E. Nagai, K. Mizumoto, N. Maehara, Y. A. Minamishima, M. Katano, K. Matsumoto, T. Nakamura, and M. Tanaka
Tumor Suppression through Angiogenesis Inhibition by SUIT-2 Pancreatic Cancer Cells Genetically Engineered to Secrete NK4
Clin. Cancer Res., October 1, 2002; 8(10): 3243 - 3249.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. A. Scappaticci
Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies
J. Clin. Oncol., September 15, 2002; 20(18): 3906 - 3927.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Ye, C. Feng, S. Wang, X. Liu, Y. Lin, and M. Li
Antiangiogenic and Antitumor Effects of Endostatin on Follicular Thyroid Carcinoma
Endocrinology, September 1, 2002; 143(9): 3522 - 3528.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Q.-R. Chen, L. Zhang, P. W. Luther, and A. J. Mixson
Optimal transfection with the HK polymer depends on its degree of branching and the pH of endocytic vesicles
Nucleic Acids Res., March 15, 2002; 30(6): 1338 - 1345.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
D. R. Sorensen, T.-A. Read, T. Porwol, B. R. Olsen, R. Timpl, T. Sasaki, P. O. Iversen, H. B. Benestad, B. K. L. Sim, and R. Bjerkvig
Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma
Neuro-oncol, January 1, 2002; 4(1): 1 - 8.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. L. Feldman, H. R. Alexander, S. M. Hewitt, D. Lorang, C. E. Thiruvathukal, E. M. Turner, and S. K. Libutti
Effect of Retroviral Endostatin Gene Transfer on Subcutaneous and Intraperitoneal Growth of Murine Tumors
J Natl Cancer Inst, July 4, 2001; 93(13): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Indraccolo, M. Morini, E. Gola, F. Carrozzino, W. Habeler, S. Minghelli, L. Santi, L. Chieco-Bianchi, Y. Cao, A. Albini, et al.
Effects of Angiostatin Gene Transfer on Functional Properties and in Vivo Growth of Kaposi's Sarcoma Cells
Cancer Res., July 1, 2001; 61(14): 5441 - 5446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Mori, A. Ando, P. Gehlbach, D. Nesbitt, K. Takahashi, D. Goldsteen, M. Penn, C. T. Chen, K. Mori, M. Melia, et al.
Inhibition of Choroidal Neovascularization by Intravenous Injection of Adenoviral Vectors Expressing Secretable Endostatin
Am. J. Pathol., July 1, 2001; 159(1): 313 - 320.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Feldman, S. K. Libutti, and A. J. Mixson
Correspondence re: Q-R. Chen et al., Liposomes Complexed to Plasmids Encoding Angiostatin and Endostatin Inhibit Breast Cancer in Nude Mice. Cancer Res., 59: 3308-3312, 1999.
Cancer Res., March 1, 2001; 60(5): 1463 - 1464.
[Full Text]


Home page
Cancer Res.Home page
I. Ding, J. Z. Sun, B. Fenton, W. M. Liu, P. Kimsely, P. Okunieff, and W. Min
Intratumoral Administration of Endostatin Plasmid Inhibits Vascular Growth and Perfusion in MCa-4 Murine Mammary Carcinomas
Cancer Res., January 1, 2001; 61(2): 526 - 531.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. K. Khanna and J. D. Hosenpud
In Vitro and In Vivo Transfection of p21 Gene Enhances Cyclosporin A-Mediated Inhibition of Lymphocyte Proliferation
J. Immunol., August 15, 2000; 165(4): 1882 - 1888.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Zhang, D. Yu, M. Hu, S. Xiong, A. Lang, L. M. Ellis, and R. E. Pollock
Wild-Type p53 Suppresses Angiogenesis in Human Leiomyosarcoma and Synovial Sarcoma by Transcriptional Suppression of Vascular Endothelial Growth Factor Expression
Cancer Res., July 1, 2000; 60(13): 3655 - 3661.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. G. Sacco, M. Caniatti, E. M. Catò, A. Frattini, G. Chiesa, R. Ceruti, F. Adorni, L. Zecca, E. Scanziani, and P. Vezzoni
Liposome-delivered Angiostatin Strongly Inhibits Tumor Growth and Metastatization in a Transgenic Model of Spontaneous Breast Cancer
Cancer Res., May 1, 2000; 60(10): 2660 - 2665.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. L. Feldman, N. P. Restifo, H. R. Alexander, D. L. Bartlett, P. Hwu, P. Seth, and S. K. Libutti
Antiangiogenic Gene Therapy of Cancer Utilizing a Recombinant Adenovirus to Elevate Systemic Endostatin Levels in Mice
Cancer Res., March 1, 2000; 60(6): 1503 - 1506.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Kuo, F. Farnebo, E. Y. Yu, R. Christofferson, R. A. Swearingen, R. Carter, H. A. von Recum, J. Yuan, J. Kamihara, E. Flynn, et al.
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
PNAS, April 10, 2001; 98(8): 4605 - 4610.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. V. Sauter, O. Martinet, W.-J. Zhang, J. Mandeli, and S. L. C. Woo
Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
PNAS, April 25, 2000; 97(9): 4802 - 4807.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.